Volume 83, Issue 6, Pages (June 2013)

Slides:



Advertisements
Similar presentations
Volume 62, Issue 6, Pages (December 2002)
Advertisements

Volume 70, Issue 1, Pages (July 2006)
Volume 74, Issue 3, Pages (August 2008)
Lymphatic vessels develop during tubulointerstitial fibrosis
Volume 78, Issue 3, Pages (August 2010)
Volume 69, Issue 3, Pages (February 2006)
Volume 68, Issue 2, Pages (August 2005)
Plasmin is not protective in experimental renal interstitial fibrosis1
Volume 76, Issue 1, Pages (July 2009)
Ontogeny of CD24 in the human kidney
Macrophages promote polycystic kidney disease progression
Volume 66, Issue 3, Pages (September 2004)
Volume 91, Issue 3, Pages (March 2017)
Volume 63, Issue 2, Pages (February 2003)
Volume 73, Issue 12, Pages (June 2008)
Volume 67, Issue 3, Pages (March 2005)
Volume 58, Issue 1, Pages (July 2000)
Volume 84, Issue 2, Pages (August 2013)
Volume 78, Issue 8, Pages (October 2010)
Volume 85, Issue 6, Pages (June 2014)
IN-1130, a novel transforming growth factor-β type I receptor kinase (ALK5) inhibitor, suppresses renal fibrosis in obstructive nephropathy  J.-A. Moon,
Volume 70, Issue 7, Pages (October 2006)
Volume 88, Issue 3, Pages (September 2015)
Volume 74, Issue 3, Pages (August 2008)
Volume 75, Issue 2, Pages (January 2009)
Volume 80, Issue 9, Pages (November 2011)
Hyperlipidemia aggravates renal disease in B6.ROP Os/+ mice
Volume 67, Issue 1, Pages (January 2005)
Kameswaran Surendran, Theodore C. Simon, Helen Liapis, John K. McGuire 
Fenghua Zeng, Tomoki Miyazawa, Lance A. Kloepfer, Raymond C. Harris 
Volume 57, Issue 6, Pages (June 2000)
Volume 87, Issue 1, Pages (January 2015)
Volume 59, Issue 1, Pages (January 2001)
Volume 69, Issue 1, Pages (January 2006)
Volume 72, Issue 3, Pages (August 2007)
Volume 80, Issue 10, Pages (November 2011)
Heterozygous disruption of activin receptor–like kinase 1 is associated with increased renal fibrosis in a mouse model of obstructive nephropathy  José.
Volume 84, Issue 5, Pages (November 2013)
Volume 73, Issue 12, Pages (June 2008)
Volume 84, Issue 5, Pages (November 2013)
The renal lesions that develop in neonatal mice during angiotensin inhibition mimic obstructive nephropathy  Yoichi Miyazaki, Shinya Tsuchida, Agnes Fogo,
Volume 63, Issue 2, Pages (February 2003)
Hepatocyte growth factor suppresses interstitial fibrosis in a mouse model of obstructive nephropathy  Shinya Mizuno, Kunio Matsumoto, Toshikazu Nakamura 
Volume 58, Issue 2, Pages (August 2000)
Activation of Erk1/2 and Akt following unilateral ureteral obstruction
Volume 78, Issue 6, Pages (September 2010)
Gregory B. Vanden Heuvel  Kidney International 
Volume 70, Issue 1, Pages (July 2006)
Volume 81, Issue 3, Pages (February 2012)
Yongji Wang, Megan L. Borchert, Hector F. DeLuca  Kidney International 
Volume 70, Issue 7, Pages (October 2006)
Volume 131, Issue 6, Pages (December 2006)
Lymphatic vessels develop during tubulointerstitial fibrosis
Role of CD8+ cells in the progression of murine adriamycin nephropathy
Volume 65, Issue 2, Pages (February 2004)
Volume 73, Issue 9, Pages (May 2008)
Volume 82, Issue 2, Pages (July 2012)
Volume 75, Issue 5, Pages (March 2009)
Volume 74, Issue 6, Pages (September 2008)
Peroxisome proliferator-activated receptor-gamma agonist is protective in podocyte injury-associated sclerosis  H.-C. Yang, L.-J. Ma, J. Ma, A.B. Fogo 
CD4+ T cells: a potential player in renal fibrosis
Volume 85, Issue 1, Pages (January 2014)
Volume 74, Issue 2, Pages (July 2008)
Volume 62, Issue 5, Pages (November 2002)
Volume 73, Issue 12, Pages (June 2008)
Volume 76, Issue 8, Pages (October 2009)
J. Ma, A. Weisberg, J.P. Griffin, D.E. Vaughan, A.B. Fogo, N.J. Brown 
Plasmin is not protective in experimental renal interstitial fibrosis1
Volume 75, Issue 2, Pages (January 2009)
Volume 79, Issue 11, Pages (June 2011)
Presentation transcript:

Volume 83, Issue 6, Pages 1099-1108 (June 2013) Cyst expansion and regression in a mouse model of polycystic kidney disease  Hester Happé, Annemieke M. van der Wal, Daniela C.F. Salvatori, Wouter N. Leonhard, Martijn H. Breuning, Emile de Heer, Dorien J.M. Peters  Kidney International  Volume 83, Issue 6, Pages 1099-1108 (June 2013) DOI: 10.1038/ki.2013.13 Copyright © 2013 International Society of Nephrology Terms and Conditions

Figure 1 Growth curves, 2KW/BW ratios, cystic indices, and blood urea levels in B6Ola-Pkd1nl,nl and wild-type mice. Body weight (g) for (a) males and (b) females are indicated in time (mean±s.e.m., n=2–7), (c) total kidney weight to body weight ratio (2KW/BW) and (d) total kidney weight (g) at different ages (median and interquertile range, IQR, n=2–7 per age), (e) cystic index (CI) represented as area-percentage (median and IQR, n=2–7 per age) and (f) blood urea concentration in time in mmol/l (mean±s.e.m., n=5–11 per age). Closed squares, B6Ola-Pkd1nl,nl mice; open diamonds, B6Ola-Pkd1wt,wt. Kidney International 2013 83, 1099-1108DOI: (10.1038/ki.2013.13) Copyright © 2013 International Society of Nephrology Terms and Conditions

Figure 2 Histopathological characteristics of cystic kidneys inB6Ola-Pkd1nl,nlmice. (a–c) Periodic acid-Schiff staining showing progression of cystic disease in B6Ola-Pkd1nl,nl mice at 4, 8, and 24 weeks of age, respectively. (d–f) α-Smooth muscle actin (SMA) staining showing myofibroblasts and (g–i) Sirius Red staining for collagen as markers for fibrosis at 4 (d, g), 8 (e, h), and 24 (f, i) weeks of age. (j–l) Nephron-segment marker staining showing dilated tubules and cysts of proximal tubular origin at D7 as indicated by staining for megalin (j), and cysts of collecting duct origin at D14 (k) and D28 (l) as indicated by staining for aquaporin-2. (m, n) Clusters of inflammatory cells in cystic kidneys showing (m) leukocytes positive for CD45 staining and (n) mature macrophages as indicated by F4/80 staining. (o) Mature macrophages indicated by F4/80 staining and (p) alternatively activated macrophages stained for CD163 underlying cystic epithelia. (m–p) Twenty-four weeks of age. (q) Example of collapsing cysts at 24 weeks of age, Sirius Red staining. (r) Stretch of, and Ki-67-positive nuclei in cystic epithelium at 4 weeks of age. (s, t) Active caspase-3 staining showing apoptotic nuclei in cystic (s) and non-cystic epithelia (t) at 4 weeks of age. Asterisk indicates immune infiltrate filling the lumen of the remnant structure of a cyst. Arrows indicate F4/80-positive cells and CD163-positive cells (granular staining) underlying cystic epithelia. Closed arrowheads indicate examples of positive nuclei in epithelia, while open arrowheads indicate positive nuclei in interstitium. C, collapsing cyst; CD, cyst derived from collecting duct; DT, cyst of distal tubular origin; PT, cyst of proximal tubular origin. Kidney International 2013 83, 1099-1108DOI: (10.1038/ki.2013.13) Copyright © 2013 International Society of Nephrology Terms and Conditions

Figure 3 Proliferation index and apoptotic index in time in B6Ola-Pkd1nl,nl and wild-type mice. (a) Proliferation index presented as percentage of Ki-67-positive nuclei over total nuclei. (b) Apoptotic index presented as percentage of active caspase-3-positive nuclei over total nuclei. Results are shown as mean±s.e.m. *P<0.05, **P<0.01. Kidney International 2013 83, 1099-1108DOI: (10.1038/ki.2013.13) Copyright © 2013 International Society of Nephrology Terms and Conditions

Figure 4 Renal mRNA expression of genes involved in matrix remodeling at different ages. mRNA expression of (a) Serpine1 (PAI-1) (b) Mmp2, (c) Fn1(EDA), and (d) Col1a1 as analyzed by reverse transcriptase-multiplex ligation-dependent probe amplification. Expression was normalized to the housekeeping gene HPRT. Results are shown as median expression relative to the expression of wild-type mice at the age of 4 weeks, error bars represent interquartile range (n=2–5). Closed squares, B6Ola-Pkd1nl,nl mice; open diamonds, B6Ola-Pkd1wt,wt. The dotted line represents 2KW/BW, indicated on the right y-axis, showing pattern of renal volume in time. *P<0.05, **P<0.01, ***P<0.001. 2KW/BW, total kidney weight to body weight ratio. Kidney International 2013 83, 1099-1108DOI: (10.1038/ki.2013.13) Copyright © 2013 International Society of Nephrology Terms and Conditions

Figure 5 Renal mRNA expression of potential biomarkers for autosomal-dominant polycystic kidney disease progression at different ages. mRNA expression of (a) Lcn2, (b) Sgp2, and (c) C3, as analyzed by reverse transcriptase-multiplex ligation-dependent probe amplification. Results are shown as median expression relative to the expression of wild-type mice at the age of 4 weeks; error bars represent interquartile range (n=2–5). Closed squares, B6Ola-Pkd1nl,nl mice; open diamonds, B6Ola-Pkd1wt,wt. The dotted line (in a and b) represents 2KW/BW, indicated on the right y-axis, showing pattern of renal volume in time.*P<0.05, **P<0.01, ***P<0.001. Kidney International 2013 83, 1099-1108DOI: (10.1038/ki.2013.13) Copyright © 2013 International Society of Nephrology Terms and Conditions